ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Top 3 Nutrients to Detox the Liver and Soothe Digestion

Natural Bladder Control, Go Less and Live More

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Omega Fix for Obesity: How the Right Fats Fight Fat

Potential of Quercetin in the Treatment of Melanoma

How Pomegranate May Protect Against Cancer

Trimming the spare tire: Canola oil may cut belly fat

Supplementation with vitamins C and E associated with decreased risk of cognitive impairment, dement...

 
Print Page
Email Article

NIAMS Launches Multiple Projects in Autoimmunity

  [ 20 votes ]   [ Discuss This Article ]
By Press Release by NIAMS • www.ProHealth.com • December 21, 1999


The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has awarded nearly $4 million for new projects on autoimmune diseases, conditions in which the body's immune cells mistakenly attack its own tissues and vital organs. The funds are part of a $30 million allocation from Congress to the National Institutes of Health (NIH) to bolster research in autoimmunity.

The awards enhance the NIAMS' already strong commitment in this area, and involve the start-up of nine projects. These projects reflect the significant presence of the NIAMS in an NIH effort against some 80 serious, chronic, autoimmune illnesses involving almost every human organ system.

"Autoimmune diseases like rheumatoid arthritis, lupus, scleroderma, alopecia areata, and many blistering skin diseases exact a huge toll in human suffering and economic costs," said NIAMS Director Stephen I. Katz, M.D., Ph.D. "But we've recently witnessed exciting research advances in several of these, and we have every intention of pushing our knowledge base further."
To extend the edge of autoimmunity research, the following projects have been funded:

Pilot Trials on Innovative Therapies for Rheumatic and Skin Diseases

"Modulation of T-Cell Responses to Shared Epitope Peptides in Rheumatoid Arthritis" (University of California, San Diego). A multicenter clinical trial involving oral administration of a small peptide in treating rheumatoid arthritis.

"Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma" (University of Tennessee, Knoxville). A second multicenter clinical trial, testing the efficacy of orally administering collagen peptides in patients with scleroderma.

Target Organ Damage in Autoimmune Diseases

"Characterizing Microfibril Abnormalities in Scleroderma" (University of Texas Health Science Center, Houston). A study of abnormalities in structure and organization in tissue fibers of people with scleroderma.

"Cytokine Regulation of RA Synoviocyte Phenotype" (Hospital for Special Surgery, New York City). A project looking at why certain anti-inflammatory signaling proteins do not reduce inflammation of the joint lining membrane in rheumatoid arthritis.

"Vasculopathy, Apoptosis, and Autoimmunity" (University of Pittsburgh). An investigation of the roles blood vessel malfunction, cell death and autoimmunity play in scleroderma.

"Growth Factor Responses in Rheumatoid Synovium" (Vanderbilt University, Nashville, Tenn.). A study of mechanisms that lead to abnormal growth patterns in cells lining the joints of people with rheumatoid arthritis.
Autoimmune Rat Repository and Transgenic Resource. This central resource and development center for rat models of autoimmune disorders is located on the NIH campus but may be used by the entire United States research community.

NIAMS Data Registries

Research Registry for Neonatal Lupus (Hospital for Joint Diseases, New York, N.Y.). This registry will enhance the search for basic defects in neonatal lupus and seek to improve diagnosis, treatment and prevention methods. Issues involving fetal heart block and cutaneous manifestations of neonatal lupus will also be examined.

Research Registry for Juvenile Rheumatoid Arthritis (Children's Hospital Medical Center, Cincinnati, Ohio). This registry focuses on multicase families with affected sibling pairs. A new major emphasis is a genome-wide search for juvenile rheumatoid arthritis susceptibility genes.

The NIAMS is also participating in an additional initiative, New Imaging Technologies for Autoimmune Diseases, through a project at Louisiana State University Medical Center in New Orleans involving in vivo imaging of tiny blood vessels in animal models of rheumatoid arthritis.

To increase collaboration and communication among organizations stimulating and supporting autoimmune research, an NIH Autoimmune Diseases Coordinating Committee was established in May 1998. The NIAMS and other NIH institutes are represented on the committee, along with other federal agencies, including the Food and Drug Administration, the Veteran's Administration and several private organizations.

Source:
National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS) Press Release. December 21, 1999.

The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases. For more information about NIAMS, call our information clearinghouse at (301) 495-4484 or visit the NIAMS web site at http://www.nih.gov/niams



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
Live Without Anxiety or Stress Live Without Anxiety or Stress
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map